Pharmacokinetics under the COVID‐19 storm-Reference-Cited by-同舟云学术

Pharmacokinetics under the COVID‐19 storm

Published:2021-01-14 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Pilla Reddy Venkatesh¹²^ORCID,El‐Khateeb Eman³⁴^ORCID,Jo Heeseung¹,Giovino Natalie⁵,Lythgoe Emily⁶,Sharma Shringi⁷,Tang Weifeng⁷,Jamei Masoud⁸,Rastomi‐Hodjegan Amin³⁸

Affiliation:

1. Modelling & Simulation, Early Oncology, R&D Oncology AstraZeneca Cambridge UK

2. Clinical Pharmacology and Quantitative Pharmacology, R&D, AstraZeneca Cambridge UK

3. Centre for Applied Pharmacokinetic Research University of Manchester Manchester UK

4. Clinical Pharmacy Department, Faculty of Pharmacy Tanta University Tanta Egypt

5. Early Oncology Clinical, R&D Oncology AstraZeneca Boston USA

6. R&D Biopharmaceuticals AstraZeneca Cambridge UK

7. Clinical Pharmacology and Quantitative Pharmacology, R&D AstraZeneca USA

8. Certara UK Limited, Simcyp Division Sheffield UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14668

Reference97 articles.

1. FDA.Enhancing the diversity of clinical trial populations – eligibility criteria enrollment practices and trial designs guidance for industry.2019 https://www.fda.gov/media/127712/download accsessed 10 October 2020.

2. Remdesivir for the Treatment of Covid-19 — Final Report

3. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

4. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

5. Administration FFD.FDA guidance on conduct of clinical trials of medical products during COVID‐19 public health emergency.2020 https://www.fda.gov/media/136238/download accessed 10 October 2020.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

2. PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies;Clinical and Translational Science;2024-07

3. COVID‐19 severity gradient differentially dysregulates clinically relevant drug processing genes in nasopharyngeal swab samples;British Journal of Clinical Pharmacology;2024-05-31

4. Development and application of a PBPK modeling strategy to support antimalarial drug development;CPT: Pharmacometrics & Systems Pharmacology;2023-08-16

5. UDCA May Promote COVID-19 Recovery: A Cohort Study with AI-Aided Analysis;2023-05-04